loading
Schlusskurs vom Vortag:
$74.17
Offen:
$72.58
24-Stunden-Volumen:
658.87K
Relative Volume:
0.80
Marktkapitalisierung:
$7.42B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
55.93
EPS:
1.26
Netto-Cashflow:
$142.60M
1W Leistung:
-1.52%
1M Leistung:
-20.05%
6M Leistung:
-3.15%
1J Leistung:
+40.78%
1-Tages-Spanne:
Value
$69.68
$73.69
1-Wochen-Bereich:
Value
$69.68
$74.27
52-Wochen-Spanne:
Value
$49.00
$117.33

Corcept Therapeutics Inc Stock (CORT) Company Profile

Name
Firmenname
Corcept Therapeutics Inc
Name
Telefon
650.688.8803
Name
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Name
Mitarbeiter
500
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-17
Name
Neueste SEC-Einreichungen
Name
CORT's Discussions on Twitter

Vergleichen Sie CORT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CORT
Corcept Therapeutics Inc
70.46 7.82B 628.56M 141.82M 142.60M 1.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.10 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
629.33 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
424.21 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
837.59 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
184.15 39.72B 447.02M -1.18B -868.57M -6.1812

Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-06 Hochstufung Truist Hold → Buy
2023-04-11 Eingeleitet SVB Securities Market Perform
2023-04-04 Eingeleitet Piper Sandler Overweight
2023-02-15 Herabstufung Jefferies Buy → Hold
2022-08-01 Herabstufung Truist Buy → Hold
2022-07-27 Hochstufung Jefferies Hold → Buy
2022-06-27 Fortgesetzt Canaccord Genuity Buy
2022-02-02 Eingeleitet Canaccord Genuity Buy
2022-01-28 Eingeleitet Truist Buy
2020-08-05 Herabstufung Jefferies Buy → Hold
2019-09-24 Eingeleitet Jefferies Buy
2019-09-06 Eingeleitet H.C. Wainwright Buy
2019-02-04 Herabstufung B. Riley FBR Buy → Neutral
2018-08-10 Bestätigt Stifel Hold
2018-05-31 Herabstufung Stifel Buy → Hold
2018-03-09 Eingeleitet B. Riley FBR, Inc. Buy
2017-08-31 Eingeleitet Stifel Buy
2017-02-02 Eingeleitet Ladenburg Thalmann Buy
2015-04-21 Eingeleitet FBR Capital Outperform
2014-01-13 Herabstufung Stifel Buy → Hold
2013-08-09 Herabstufung Janney Buy → Neutral
2013-08-09 Herabstufung Ladenburg Thalmann Buy → Neutral
2012-02-21 Bestätigt JMP Securities Mkt Outperform
2010-01-06 Hochstufung Ladenburg Thalmann Neutral → Buy
2008-07-17 Eingeleitet Rodman & Renshaw Mkt Outperform
2007-06-21 Hochstufung Punk, Ziegel & Co Mkt Perform → Accumulate
Alle ansehen

Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten

pulisher
09:36 AM

What Does Wall Street Think About Corcept Therapeutics (CORT)? - Yahoo Finance

09:36 AM
pulisher
07:04 AM

Risk vs reward if holding onto Corcept Therapeutics IncorporatedJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com

07:04 AM
pulisher
05:43 AM

Is Corcept Therapeutics Incorporated stock positioned well for digital economy2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com

05:43 AM
pulisher
05:16 AM

Will Corcept Therapeutics Incorporated stock recover after recent dropInsider Buying & Breakout Confirmation Trade Signals - newser.com

05:16 AM
pulisher
04:12 AM

Will a bounce in Corcept Therapeutics Incorporated offer an exit2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com

04:12 AM
pulisher
04:05 AM

What hedge fund moves indicate for Corcept Therapeutics Incorporated (HTD) stockQuarterly Trade Report & Low Risk Entry Point Guides - newser.com

04:05 AM
pulisher
03:53 AM

Corcept Therapeutics Incorporated $CORT Shares Sold by Assetmark Inc. - MarketBeat

03:53 AM
pulisher
01:46 AM

Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsEarnings Summary Report & Daily Stock Momentum Reports - newser.com

01:46 AM
pulisher
Nov 03, 2025

Is Corcept Therapeutics Incorporated (HTD) stock a top pick for value investorsMarket Rally & Long-Term Safe Investment Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Does Corcept Therapeutics Incorporated qualify in momentum factor screeningMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Historical Comparison & Stock Portfolio Risk Management - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Detecting support and resistance levels for Corcept Therapeutics IncorporatedJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using data models to predict Corcept Therapeutics Incorporated stock movementWeekly Profit Report & Community Verified Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Corcept Therapeutics Incorporated stock attractive for income investors2025 Geopolitical Influence & Weekly High Momentum Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How hedge fund analytics apply to Corcept Therapeutics Incorporated stockJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How high can Corcept Therapeutics Incorporated stock go2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Corcept Earnings: What To Look For From CORT - The Globe and Mail

Nov 03, 2025
pulisher
Nov 03, 2025

Is Corcept Therapeutics Incorporated stock affected by interest rate hikesMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Key metrics from Corcept Therapeutics Incorporated’s quarterly data2025 Retail Activity & Target Return Focused Stock Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Corcept Therapeutics Incorporat (CORT) stock forecast and price target - Yahoo! Finance UK

Nov 02, 2025
pulisher
Nov 02, 2025

Does Corcept Therapeutics Incorporated (HTD) stock trade below intrinsic valueJuly 2025 Summary & Risk Managed Investment Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Corcept Therapeutics Incorporated stock compares to growth peersMarket Activity Summary & AI Optimized Trading Strategy Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Y Intercept Hong Kong Ltd Purchases 11,881 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Building trade automation scripts for Corcept Therapeutics IncorporatedDay Trade & Precise Buy Zone Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

What momentum indicators show for Corcept Therapeutics Incorporated stockPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Corcept Therapeutics Incorporated (HTD) stock enhance shareholder valuePrice Action & AI Forecasted Entry/Exit Points - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Using Bollinger Bands to evaluate Corcept Therapeutics IncorporatedJobs Report & Daily Entry Point Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Corcept Therapeutics Inc expected to post earnings of 14 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Emerald Mutual Fund Advisers Trust Acquires 113,088 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Will Corcept Therapeutics Incorporated stock recover faster than market2025 Short Interest & Fast Gaining Stock Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How reliable is Corcept Therapeutics Incorporated (HTD) stock dividend growthMarket Risk Report & Fast Moving Stock Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Corcept Therapeutics Incorporated (CORT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

What Corcept Therapeutics (CORT)'s Phase 3 Relacorilant Data Means for Shareholders - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Corcept’s (CORT) Multibagger Momentum Builds on Relacorilant and Expanding Commercial Footprint - MSN

Oct 30, 2025

Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.73
price up icon 1.19%
$28.89
price up icon 0.66%
$102.00
price up icon 0.46%
$104.18
price up icon 0.26%
biotechnology ONC
$310.17
price down icon 0.47%
$183.86
price down icon 1.22%
Kapitalisierung:     |  Volumen (24h):